BREAKWATER safety lead-in (SLI): Encorafenib + cetuximab (EC) +- chemotherapy for first-line (1L) treatment (tx) of BRAF V600E-mutant ( BRAF V600E ) metastatic colorectal cancer (mCRC).
Cetuximab;Encorafenib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: BREAKWATER safety lead-in (SLI): Encorafenib + cetuximab (EC) +- chemotherapy for first-line (1L) treatment (tx) of BRAF V600E-mutant ( BRAF V600E ) metastatic colorectal cancer (mCRC). ### Output: Cetuximab;Encorafenib